Literature DB >> 31461000

Effect of Body Mass Index on Outcomes after Prepectoral Breast Reconstruction.

Allen Gabriel1, Steven Sigalove1, Noemi M Sigalove1, Toni L Storm-Dickerson1, Nicole Pope1, Jami Rice1, G Patrick Maxwell1.   

Abstract

BACKGROUND: Body mass index has been shown to be a predictor of outcomes after subpectoral expander/implant reconstruction, with every unit increase in body mass index increasing the risk of complications by approximately 6 percent. The effect of body mass index on complications after prepectoral reconstruction has not yet been evaluated and is the purpose of this study.
METHODS: A total of 366 reconstructed breasts from 197 patients were stratified into five body mass index groups (normal; overweight; and class I, class II, and class III, obese) and postoperative complications were compared across the groups. Additional analyses were performed using broad classifications of body mass index into nonobese and obese in addition to normal, overweight, and obese. Body mass index as an independent predictor of complications was assessed using multivariate logistic regression analysis.
RESULTS: Complication rates did not differ significantly across body mass index groups when using the broad classifications. With five-group stratification, significantly higher rates of return to operating room, expander/implant loss, skin necrosis, wound dehiscence, and overall complications were seen in class II and/or class III obese versus overweight patients. However, on multivariate logistic regression analyses, body mass index, as a continuous variable, did not independently predict any complication. Diabetes and smoking emerged as significant predictors of any complication, indicating that these factors, rather than body mass index, were driving the increased rates of complications seen in the high-body mass index groups.
CONCLUSION: Body mass index alone is not a predictor of outcomes after prepectoral expander/implant breast reconstruction and should not be used to estimate risk of postoperative complications or exclude patients for prepectoral reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

Entities:  

Mesh:

Year:  2019        PMID: 31461000     DOI: 10.1097/PRS.0000000000005901

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

Review 1.  Breast reconstruction in the high-risk population: current review of the literature and practice guidelines.

Authors:  Margaret S Roubaud; Joseph N Carey; Emma Vartanian; Ketan M Patel
Journal:  Gland Surg       Date:  2021-01

2.  Pre-pectoral one-stage breast reconstruction with anterior biological acellular dermal matrix coverage.

Authors:  Ayesha Khan; Marios-Konstantinos Tasoulis; Victoria Teoh; Aleksandra Tanska; Ruth Edmonds; Gerald Gui
Journal:  Gland Surg       Date:  2021-03

3.  Gender-Affirming Mastectomy in Transmasculine Patients: Does Obesity Increase Complications or Revisions?

Authors:  Kara A Rothenberg; Rebecca C Gologorsky; J Carlo Hojilla; Annie Tang; Caitlin M Cohan; Genna Beattie; Karen M Yokoo
Journal:  Ann Plast Surg       Date:  2021-07-01       Impact factor: 1.763

4.  Povidone-iodine Does Not Affect Acellular Dermal Matrix Integration in Patients Undergoing 2-staged, Prepectoral, Breast Reconstructive Surgery.

Authors:  Allen Gabriel; Steven Sigalove; Maci Pfaffenberger; Elizabeth Eldenburg; Rebecca Gold; Erin O'Rorke; G Patrick Maxwell
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-23

5.  BMI Specific Complications Following Implant-Based Breast Reconstruction after Mastectomy.

Authors:  Helena Sophie Leitner; Reinhard Pauzenberger; Ines Ana Ederer; Christine Radtke; Stefan Hacker
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

6.  Prepectoral Breast Reconstruction in Morbidly Obese Patients.

Authors:  Allen Gabriel; Toni L Storm-Dickerson; Vivian Chan; Rob Lord; Erin O'Rorke; G Patrick Maxwell
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.